ArticleBMC health services research2026
Comparing mental health professionals' willingness to use digital therapeutics: a cross-national survey in South Korea and Germany.
Article in BMC health services research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDigital therapeutics (DTx) are software-based medical interventions used to prevent, manage, or treat health conditions. As mental health DTx become more prevalent, understanding clinicians’ willingness to use them and the systemic and individual factors that shape that willingness is critical for effective implementation. This study aimed to compare perceptions of DTx among mental health professionals in South Korea and Germany.
methodsA cross-sectional, web-based survey was conducted between February and May 2024 among mental health professionals in South Korea and Germany. The survey assessed participant characteristics, digital technology use, willingness to use DTx, perceived applicability, motivations, and related concerns. Group differences between countries were analyzed, and logistic regression was used to identify predictors of willingness to use DTx. Exploratory analyses examined differences across professional groups.
resultsA total of 237 participants completed the survey (South Korea: n = 133; Germany: n = 104). Overall, 63.7% (n = 151) reported willingness to use DTx, with a significantly higher proportion in Germany than in South Korea (71.2% vs 57.9%; p = 0.035). Significant differences were observed in expected DTx functionalities and perceived applicability across mental health conditions. South Korean clinicians reported higher willingness to use AI-based chatbots, wearable-supported monitoring, and digital psychotherapy, whereas German clinicians reported higher willingness to use relaxation-based interventions. Perceived applicability also differed by country: South Korean participants more frequently considered DTx suitable for stress-related and childhood/adolescent-onset disorders, while German participants more frequently considered them suitable for substance use and schizophrenia spectrum disorders. In multivariable analysis, higher technological readiness (OR = 4.92, 95% CI 2.19–11.09; p < 0.001), residence in Germany (OR = 3.37, 95% CI 1.53–7.42; p = 0.003), and being a medical doctor (OR = 2.78, 95% CI 1.23–6.25; p = 0.027) were associated with greater willingness to use DTx.
conclusionsClinicians in both countries reported willingness to use DTx, although levels varied by country, profession, and level of digital engagement. Addressing common and context-specific barriers, including training, reimbursement mechanisms, and regulatory clarity, could support broader use of DTx in mental health care. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.